Free Trial

Prime Medicine (PRME) SEC Filings & 10K Form

Prime Medicine logo
$1.29 +0.06 (+4.88%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$1.28 -0.01 (-1.09%)
As of 05/23/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Prime Medicine SEC Filings

DateFilerForm TypeView
05/22/2025
3:18 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:21 PM
LEE ANN L. (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:22 PM
Brudnick Richard (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
6:44 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
6:45 PM
Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:09 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
8:12 AM
Prime Medicine (Filer)
Form DEFA14A
05/12/2025
3:48 PM
LEE ANN L. (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
3:50 PM
Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
3:50 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:05 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:08 AM
Prime Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2025
5:19 AM
Prime Medicine (Filer)
Form ARS
04/22/2025
5:09 AM
Prime Medicine (Filer)
Form DEFA14A
04/22/2025
5:07 AM
Prime Medicine (Filer)
Form DEF 14A
03/18/2025
6:15 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
7:11 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:12 PM
Brudnick Richard (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:14 PM
LEE ANN L. (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:15 PM
Duffield Jeremy (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:16 PM
Goldwasser Meredith (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:18 PM
Alenson Carman (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
7:13 AM
Prime Medicine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2025
7:21 AM
Prime Medicine (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
7:02 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:01 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2024
11:15 PM
Prime Medicine (Filer)
Form EFFECT
12/13/2024
7:18 AM
Prime Medicine (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/09/2024
5:22 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:22 PM
Brudnick Richard (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:23 PM
Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:32 PM
ARCH Venture Fund XII, L.P. (Filed by)
Prime Medicine (Subject)
Form SC 13D/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Prime Medicine (Subject)
Form SC 13G/A
10/24/2024
7:04 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:29 PM
Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:20 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Prime Medicine (Subject)
Form SC 13G
09/30/2024
6:38 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:26 AM
Prime Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:08 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:18 PM
Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:PRME) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners